Target intelligence / Profile preview

Influenza A virus polymerase acidic protein cap-dependent endonuclease domain (PA-Nter)

Target
PA-Nter
Molecular classification
Enzyme, Endonuclease, RNA-dependent RNA polymerase subunit
01

Overview

The Influenza A virus polymerase acidic (PA) protein cap-dependent endonuclease domain is a critical component of the viral RNA-dependent RNA polymerase (RdRp) complex (UniProt P03433). This domain, located at the N-terminus of the PA subunit (PA-Nter), is responsible for the cap-snatching process, where it cleaves the 5' methylated cap from host cellular pre-mRNAs (Dias et al., Nature 2009). These stolen caps serve as primers for the synthesis of viral mRNA, making the endonuclease essential for viral replication. Because this mechanism is unique to the virus and lacks a direct human homolog, it represents a highly specific therapeutic target. Drugs like baloxavir marboxil target this site by chelating the divalent metal ions (manganese or magnesium) required for the enzyme's catalytic activity (Noshi et al., Antiviral Res 2018). Inhibition of this domain effectively halts the production of viral proteins and the spread of the infection within the host (FDA, Xofluza Label).

Other names
PA endonucleaseInfluenza A virus PA subunit N-terminal domainCap-dependent endonucleasePA-CEN
02

Mechanism of action

Inhibition of the cap-dependent endonuclease activity of the PA subunit, which prevents the virus from snatching the 5' cap from host pre-mRNAs, thereby blocking viral mRNA synthesis and replication.

03

Biological functions

Viral replicationCap-snatchingRNA cleavageTranscription
04

Disease associations

InfectionInfluenza A
05

Safety considerations

Emergence of resistance mutations (e.g., I38T)Potential for reduced susceptibility in specific viral strains
06

Interacting drugs

Baloxavir marboxil

1 more in the full profile.

07

Biomarkers

PA I38T mutationPA I38M mutationPA I38F mutationViral load

Beyond the preview

Go deeper on Influenza A virus polymerase acidic protein cap-dependent endonuclease domain (PA-Nter).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Influenza A virus polymerase acidic protein cap-dependent endonuclease domain (PA-Nter).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call